COPPELL, Texas--(BUSINESS WIRE)--Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, will be saluting its Hong Kong-area business leaders at its Mannatech Vision Program (MVP) event, featuring the company’s CEO and President, Alfredo “Al” Bala, Mannatech’s Regional President of Asia, Patrick Park, and company co-founder and member of the Board of Directors, Ray Robbins.
The Mannatech Hong Kong MVP event is set for Sunday, Aug. 7, 2-5 p.m. at the Holiday Inn Golden Mile’s Crystal Ballroom, located at 50 Nathan Road, Tsim Sha Tsui, Kowloon, Hong Kong.
This event allows Mannatech to train, celebrate and recognize its independent sales Associates from the area. These Associates have taken the Mannatech business opportunity to help improve the health and wellness of themselves, their families and their customers while creating economic opportunities for those seeking to create strong, long-term businesses.
Along with recognizing outstanding Associates, Park will share his vision for Mannatech in Asia, Bala will speak about how Mannatech is transforming lives around the world and the company’s future in Asia and Robbins will tell the story of how Mannatech started and how it became a worldwide success. Top field leaders will also share their stories of how they succeeded with Mannatech and how the opportunity supports their entrepreneurial efforts.
“This is an exciting event for Mannatech in Hong Kong where we put our Associates front-and-center to show our appreciation for their contributions to the company and the area economy,” said Mannatech Hong Kong’s General Manager, Roger Hsueh. “It is also a great honor to have company leaders, such as our president of Asia Mannatech, Mannatech’s co-founder and our global CEO, attend this event, share their insights and receive their accolades. This is an exciting time for Mannatech in Hong Kong and in Asia.”
The event will also include entertainment from a lion dancing troupe and drawings for valuable prizes and products.
Those wishing to attend the event can register and purchase their ticket online by visiting http://www.cvent.com/d/lvqnhp.
Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech transforms lives, providing an unprecedented level of natural wellness, freedom and purpose.* With more than 20 years of experience and operations in more than 25 countries, Mannatech is committed to transforming lives. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.